According to the latest report by IMARC Group “Eye Health Supplements Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The global eye health supplements market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the global market to grow at a CAGR of around 6% during the forecast period (2021-2026).
Eye health supplements assist in preserving vision and maintaining overall eye health. They also minimize the risk of cataracts, age-related macular degeneration (AMD) and other vision disorders, which may lead to partial or complete blindness. They comprise nutrients like essential fatty acids that are beneficial for proper visual and retinal function. As a result, their demand is escalating across the globe.
Request for a free sample copy of this report: https://www.imarcgroup.com/eye-health-supplements-market/requestsample
Market Trends:
Significant hours spent on computers, tablets, and smartphones are increasing the risk of developing computer vision syndrome (CVS) and myopia. This, along with the growing geriatric population, is positively influencing the sales of eye health supplements worldwide. Apart from this, the increasing awareness among individuals about the alternatives available for preventing different eye conditions is also fueling the growth of the market. Furthermore, governing agencies of various countries are investing in clinical studies to improve the understanding of nutrients on eye health. This is anticipated to offer lucrative opportunities to market players.
Breakup by Ingredient Type:
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Others
Breakup by Indication:
- Age-related Macular Degeneration (AMD)
- Cataract
- Dry Eye Syndrome
- Inflammation
- Others
Breakup by Formulation:
- Tablets
- Capsules
- Powder
- Others
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Alliance Pharma PLC
- Amway International (Alticor)
- Bausch & Lomb Incorporated
- Eyescience Labs
- Kemin Industries Inc.
- Novartis AG
- NutraChamps
- Nutrivein
- Pfizer Inc.
- The Nature’s Bounty Co.
- Vitabiotics Ltd.
- ZeaVision LLC.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/eye-health-supplements-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No (D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
